4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate tax issues, including deferral and device tax Tax reform

LobbyistCovered position, as disclosed
ALEXANDER DAHL —
MICHAEL B LEVY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform - 21st Century Cures Act Availability of medical products

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
LAURA JOHNSON BOLLIER —
ALEXANDER DAHL —
MICHAEL B LEVY —
BRIAN WILD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 598 (114th), H.R. 1130 (114th)

Medicare/Medicaid MMM

Funding issues for Medicare Part B 340 B drug discount program

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
LAURA JOHNSON BOLLIER —
ALEXANDER DAHL —
MICHAEL B LEVY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Trade Promotion Authority Trans-Pacific Partnership

LobbyistCovered position, as disclosed
CATE MCCANLESS BLANKENBURG —
ALEXANDER DAHL —
MICHAEL B LEVY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.